U.S. Food and Drug Administration, Center for Drug Evaluation and Research
FDA Drug Safety Podcasts
Mantente informado con discusiones perspicaces sobre actualizaciones de seguridad de medicamentos y comunicaciones de la FDA, ayudándote a tomar mejores decisiones para tu salud y bienestar.
Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic acid) to treat primary biliary cholangitis
5 mins • Jan 2, 2025
Charts
- 81Decreased by 23
- 162Decreased by 10
- 54Decreased by 18
- 158Decreased by 49
- 179Decreased by 102
Episodios recientes

Jan 2, 2025
Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic acid) to treat primary biliary cholangitis
5 mins

Sep 20, 2024
FDA adds warning about rare occurrence of serious liver injury with use of Veozah (fezolinetant) for hot flashes due to menopause
4 mins

Feb 6, 2024
FDA adds Boxed Warning for increased risk of severe hypocalcemia in patients with advanced chronic kidney disease taking osteoporosis medicine Prolia (denosumab)
4 mins

Jan 26, 2024
Update on FDA’s ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity
4 mins

Dec 8, 2023
FDA warns of rare but serious drug reaction to the antiseizure medicines levetiracetam (Keppra, Keppra XR, Elepsia XR, Spritam) and clobazam (Onfi, Sympazan)
5 mins

Idioma
Inglés
País
Estados Unidos
Sitio web
Feed
Solicitar una actualización
Las actualizaciones pueden tardar unos minutos.